Helius is a New Zealand-owned biotechnology company focused on medicinal cannabis research and development. The country’s largest licensed producer and the first medicinal cannabis cultivator to be certified as New Zealand Grown through Buy NZ Made Campaign, Helius a leader in this nascent market. The company operates a state-of-the-art GMP facility in Auckland with indoor controlled growing systems, integrated extraction site, an advanced cannabinoid research laboratory and manufacturing operations. Following changes in New Zealand’s regulatory environment, Helius is poised to set the standard for effective and accessible medicinal cannabis products.

Biotechnology

Helius Therapeutics

Paul Manning

Mary Alice Simon

Mark Woods

Gavin Pook

Nick Williams

JP Schmidt

Carmen Doran

Dr Jim Polston

Leila De Koster

Bruce Wallace

The executive team at Helius Therapeutics has a wide range of experience in different industries. Board members have experience with the New Zealand Medical Cannabis Council and Track Tec Racing. The General Manager/Site Head has experience with Siegfried Holding AG and Tracks Business Consulting Ltd. Lastly, the Director & Consultant has experience with the University of Canterbury in both Biomedical and Mechanical Engineering.

CEO and Executive Team

Leadership Team

Board of Directors

CEO and Executive Team

About

Team members

Other teams at Helius Therapeutics

Leadership Team

Board of Directors